In contrast, previous studies reported a high BRCA1/2 mutation frequency of 15.2–15.4% and a non-BRCA mutation rate of 15.4% in Chinese male breast cancer patients (Gavande et al., 2016; Li et al., 2019). This evidence concerns the gene BRCA1 and breast carcinoma.